UPDATED ON JAN 09, 2021 09:33 AM IST
Bolsonaro's letter, released by his press office, comes amid growing pressure to speed up Brazil's vaccine rollout and end the world's second-deadliest coronavirus outbreak.
By hindustantimes.com | Edited by Ayshee Bhaduri | HIndustan Times, New Delhi
UPDATED ON DEC 30, 2020 05:27 PM IST
Researchers have stressed time and again that regardless of the dosing regime, none of the trial participants developed severe coronavirus symptoms or had to go into hospital with the disease after having just one dose of the vaccine.
By Agence France-Presse | Posted by Prashasti Singh | Mumbai
UPDATED ON DEC 08, 2020 12:07 AM IST
India is the world’s second-worst hit by the coronavirus pandemic after the United States, and has recorded nearly 9.7 million infections and more than 140,000 deaths.
By Prasun Sonwalkar , edited by Vinod Janardhanan | Hindustan Times, London
UPDATED ON NOV 23, 2020 06:55 PM IST
The analysis of its data from the trial in the UK and Brazil said the AZD1222 vaccine is highly effective in preventing Covid-19, with no hospitalisations or severe cases reported in participants receiving the vaccine.
By hindustantimes.com | Edited by Prashasti Singh | Hindustan Times, New Delhi
UPDATED ON OCT 14, 2020 02:25 PM IST
“Serum is conducting Phase-3 trials as part of international trials in India, and the progress is on track. Results are expected by November or early December,” Niti Aayog member Dr V K Paul said.
By Press Trust of India | Posted by Shivani Kumar | New Delhi, Delhi
UPDATED ON SEP 16, 2020 08:29 AM IST
The DCGI, however, put certain conditions like taking extra care during screening, providing additional information in informed consent and close monitoring for adverse events during follow-up of the study which have to be “scrupulously” followed by Serum Institute of India (SII).
By Reuters | Posted by Prashasti Singh | Geneva/Manila
UPDATED ON AUG 19, 2020 06:35 AM IST
“We need to prevent vaccine nationalism,” Tedros told a virtual briefing. “Sharing finite supplies strategically and globally is actually in each country’s national interest.”
By Press Trust of India| Posted by Susmita Pakrasi | London
PUBLISHED ON JUL 30, 2020 06:10 PM IST
The researchers from National Institute of Allergy and Infectious Diseases in the US and the Oxford University found that the ChAdOx1 nCoV-19 vaccine protects the macaques from Covid-19 pneumonia -- a complication of SARS-CoV-2 infection in which the lungs become inflamed and may fill with fluid.
By HT Correspondent | Hindustan Times, London
PUBLISHED ON APR 29, 2020 03:00 AM IST
ChAdOx1 MERS vaccine is currently undergoing human trials in the UK since last week. The trial covering thousands of volunteers in Bristol, London, Southampton and Oxford is seen to be ahead of the nearly 80 similar projects across the globe.